Trials that use: Multiplicity adjustment
New to this method? Read the tutorial →
20,317 results
- Study of REGN1500 in Participants With Homozygous Familial Hypercholesterolemia (HoFH): Complete Statistical AnalysisIndependent statistical analysis of Study of REGN1500 in Participants With Homozygous Familial Hypercholesterolemia (HoFH): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02265952).
- Study of Relugolix With Estradiol and Norethindrone Acetate in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids: Complete Statistical AnalysisIndependent statistical analysis of Study of Relugolix With Estradiol and Norethindrone Acetate in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Study of Repeat Intranodal Injection of Memgen’s Cancer Vaccine, Ad-ISF35, in Subjects With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): Complete Statistical AnalysisIndependent statistical analysis of Study of Repeat Intranodal Injection of Memgen's Cancer Vaccine, Ad-ISF35, in Subjects With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): primary endpoint results, effect estimate with confidence interval, sample-size…
- Study of Repetitive Transcranial Magnetic Stimulation (rTMS) in Depressed Teens: Complete Statistical AnalysisIndependent statistical analysis of Study of Repetitive Transcranial Magnetic Stimulation (rTMS) in Depressed Teens: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01502033).
- Study of Rhopressa® for the Reduction of Elevated Intraocular Pressure in Patients With Glaucoma or Ocular Hypertension in a Real-world Setting: Complete Statistical AnalysisIndependent statistical analysis of Study of Rhopressa® for the Reduction of Elevated Intraocular Pressure in Patients With Glaucoma or Ocular Hypertension in a Real-world Setting: primary endpoint results, effect estimate with confidence…
- Study of Rivoglitazone in Type 2 Diabetes Mellitus: Complete Statistical AnalysisIndependent statistical analysis of Study of Rivoglitazone in Type 2 Diabetes Mellitus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00484198).
- Study of Romiplostim for Chemotherapy Induced Thrombocytopenia: Complete Statistical AnalysisIndependent statistical analysis of Study of Romiplostim for Chemotherapy Induced Thrombocytopenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02052882).
- Study of Roxadustat in Non-Dialysis Chronic Kidney Disease Participants With Anemia: Complete Statistical AnalysisIndependent statistical analysis of Study of Roxadustat in Non-Dialysis Chronic Kidney Disease Participants With Anemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Study of RSVpreF Vaccination and RSV Challenge in Healthy Adults: Complete Statistical AnalysisIndependent statistical analysis of Study of RSVpreF Vaccination and RSV Challenge in Healthy Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04785612).
- Study of Ruxolitinib in Colorectal Cancer Patients: Complete Statistical AnalysisIndependent statistical analysis of Study of Ruxolitinib in Colorectal Cancer Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02119676).
- Study of Ruxolitinib in Pancreatic Cancer Patients (Janus 1): Complete Statistical AnalysisIndependent statistical analysis of Study of Ruxolitinib in Pancreatic Cancer Patients (Janus 1): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02117479).
- Study of RVT-1401 for the Treatment of Patients With Moderate to Severe Active Graves’ Ophthalmopathy (GO): Complete Statistical AnalysisIndependent statistical analysis of Study of RVT-1401 for the Treatment of Patients With Moderate to Severe Active Graves' Ophthalmopathy (GO): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Study of Safety and Efficacy of a Sequential Regimen Consisting of Three Cycles of Fludarabine Followed by Tositumomab and Iodine I 131 Tositumomab: Complete Statistical AnalysisIndependent statistical analysis of Study of Safety and Efficacy of a Sequential Regimen Consisting of Three Cycles of Fludarabine Followed by Tositumomab and Iodine I 131 Tositumomab: primary endpoint results, effect estimate…
- Study of Safety and Efficacy of an Oral Contraceptive: Complete Statistical AnalysisIndependent statistical analysis of Study of Safety and Efficacy of an Oral Contraceptive: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00391807).
- Study of Safety and Efficacy of an Oral Contraceptive: Complete Statistical AnalysisIndependent statistical analysis of Study of Safety and Efficacy of an Oral Contraceptive: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00932321).
- Study of Safety and Efficacy of Brolucizumab 6 mg Drug Product Intended for Commercialization in Patients With nAMD: Complete Statistical AnalysisIndependent statistical analysis of Study of Safety and Efficacy of Brolucizumab 6 mg Drug Product Intended for Commercialization in Patients With nAMD: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Study Of Safety And Efficacy Of Ertugliflozin (PF-04971729, MK-8835) In Participants With Type 2 Diabetes (MK-8835-016): Complete Statistical AnalysisIndependent statistical analysis of Study Of Safety And Efficacy Of Ertugliflozin (PF-04971729, MK-8835) In Participants With Type 2 Diabetes (MK-8835-016): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Study of Safety and Efficacy Of Ertugliflozin (PF-04971729, MK-8835) In Participants With Type 2 Diabetes And Hypertension (MK-8835-042): Complete Statistical AnalysisIndependent statistical analysis of Study of Safety and Efficacy Of Ertugliflozin (PF-04971729, MK-8835) In Participants With Type 2 Diabetes And Hypertension (MK-8835-042): primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Study of Safety and Efficacy of Talimogene Laherparepvec With Cisplatin and Radiotherapy for Treatment of Locally Advanced Head and Neck Cancer: Complete Statistical AnalysisIndependent statistical analysis of Study of Safety and Efficacy of Talimogene Laherparepvec With Cisplatin and Radiotherapy for Treatment of Locally Advanced Head and Neck Cancer: primary endpoint results, effect estimate with confidence…
- Study of Safety and Immunogenicity of Fluzone® in Healthy Children: Complete Statistical AnalysisIndependent statistical analysis of Study of Safety and Immunogenicity of Fluzone® in Healthy Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00831675).
- Study of Safety and Performance of a Novel Ocular Lubricant in Subjects With Dry Eye Disease: Complete Statistical AnalysisIndependent statistical analysis of Study of Safety and Performance of a Novel Ocular Lubricant in Subjects With Dry Eye Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Study of Safety of Foradil in Patients With Persistent Asthma: Complete Statistical AnalysisIndependent statistical analysis of Study of Safety of Foradil in Patients With Persistent Asthma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01845025).
- Study of Safety, Pharmacokinetics, and Antitumor Activity of BGB-3245 in Participants With Advanced or Refractory Tumors: Complete Statistical AnalysisIndependent statistical analysis of Study of Safety, Pharmacokinetics, and Antitumor Activity of BGB-3245 in Participants With Advanced or Refractory Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Study of Safety, Tolerability and Effectiveness of A-101 in Subjects With Seborrheic Keratosis: Complete Statistical AnalysisIndependent statistical analysis of Study of Safety, Tolerability and Effectiveness of A-101 in Subjects With Seborrheic Keratosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Study of Safety, Tolerability and Immunogenicity of Gardasil®9 in Immunocompromised Patients: Complete Statistical AnalysisIndependent statistical analysis of Study of Safety, Tolerability and Immunogenicity of Gardasil®9 in Immunocompromised Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Study of Safety, Tolerability, and Efficacy of Ustekinumab for Symptomatic Gastrointestinal Inflammation Associated With Common Variable Immunodeficiency: Complete Statistical AnalysisIndependent statistical analysis of Study of Safety, Tolerability, and Efficacy of Ustekinumab for Symptomatic Gastrointestinal Inflammation Associated With Common Variable Immunodeficiency: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Study of Safety, Tolerability, Pharmacokinetics, and Efficacy of ABT-SLV187 in Subjects With Advanced Parkinson’s Disease: Complete Statistical AnalysisIndependent statistical analysis of Study of Safety, Tolerability, Pharmacokinetics, and Efficacy of ABT-SLV187 in Subjects With Advanced Parkinson's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Study of Saxagliptin, 5-Hydroxy Saxagliptin, and Metformin Concentrations/Levels in Pediatric Subjects With T2DM: Complete Statistical AnalysisIndependent statistical analysis of Study of Saxagliptin, 5-Hydroxy Saxagliptin, and Metformin Concentrations/Levels in Pediatric Subjects With T2DM: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Study of Selective BRAF Kinase Inhibitor Dabrafenib Monotherapy Twice Daily and in Combination With Dabrafenib Twice Daily and Trametinib Once Daily in Combination Therapy in Subjects With BRAF V600E Mutation Positive Metastatic (Stage IV) Non-small Cell Lung Cancer.: Complete Statistical AnalysisIndependent statistical analysis of Study of Selective BRAF Kinase Inhibitor Dabrafenib Monotherapy Twice Daily and in Combination With Dabrafenib Twice Daily and Trametinib Once Daily in Combination Therapy in Subjects With BRAF…
- Study of Self-monitoring of Weight & Blood Pressure (Via patientMpower Platform) in Hemodialysis: Complete Statistical AnalysisIndependent statistical analysis of Study of Self-monitoring of Weight & Blood Pressure (Via patientMpower Platform) in Hemodialysis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Study of Sequential Administration of Oral 6-Thioguanine After Methotrexate in Patients With LCH: Complete Statistical AnalysisIndependent statistical analysis of Study of Sequential Administration of Oral 6-Thioguanine After Methotrexate in Patients With LCH: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors: Complete Statistical AnalysisIndependent statistical analysis of Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Study Of Single-dose Cyclophosphamide +Pembrolizumab In Patients With Metastatic Triple Negative Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Study Of Single-dose Cyclophosphamide +Pembrolizumab In Patients With Metastatic Triple Negative Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Study of Sirolimus Therapy for Segmental Overgrowth Caused by Somatic PI3K Activation: Complete Statistical AnalysisIndependent statistical analysis of Study of Sirolimus Therapy for Segmental Overgrowth Caused by Somatic PI3K Activation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Study of Sitagliptin for the Treatment of Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Insulin (MK-0431-260): Complete Statistical AnalysisIndependent statistical analysis of Study of Sitagliptin for the Treatment of Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Insulin (MK-0431-260): primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Study of Sonrotoclax (BGB-11417) Monotherapy in Participants With Relapsed or Refractory Mantle Cell Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Study of Sonrotoclax (BGB-11417) Monotherapy in Participants With Relapsed or Refractory Mantle Cell Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Study of Sotatercept for the Treatment of Chemotherapy Induced Anemia in Patients With Metastatic Breast Cancer (MK-7962-012): Complete Statistical AnalysisIndependent statistical analysis of Study of Sotatercept for the Treatment of Chemotherapy Induced Anemia in Patients With Metastatic Breast Cancer (MK-7962-012): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Study of SPM 962 in Patients With Restless Legs Syndrome (RLS): Complete Statistical AnalysisIndependent statistical analysis of Study of SPM 962 in Patients With Restless Legs Syndrome (RLS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Study of SPR001 in Adults With Classic Congenital Adrenal Hyperplasia: Complete Statistical AnalysisIndependent statistical analysis of Study of SPR001 in Adults With Classic Congenital Adrenal Hyperplasia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03257462).
- Study of Stapled Transanal Rectal Resection (STARR) Surgery in Refractory Constipation Associated With Obstructive Defecation Syndrome (ODS): Complete Statistical AnalysisIndependent statistical analysis of Study of Stapled Transanal Rectal Resection (STARR) Surgery in Refractory Constipation Associated With Obstructive Defecation Syndrome (ODS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Study Of SU011248 In Combination With Docetaxel In Patients With Metastatic Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Study Of SU011248 In Combination With Docetaxel In Patients With Metastatic Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Study of Subcutaneous Golimumab in Chinese Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy: Complete Statistical AnalysisIndependent statistical analysis of Study of Subcutaneous Golimumab in Chinese Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Study of Subcutaneous Immune Globulin in Patients Requiring IgG Replacement Therapy: Complete Statistical AnalysisIndependent statistical analysis of Study of Subcutaneous Immune Globulin in Patients Requiring IgG Replacement Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Study of Subcutaneous Risankizumab Injection Compared to Oral Apremilast Tablets to Assess Change in Disease Activity And Adverse Events in Adult Participants With Moderate Plaque Psoriasis Who Are Candidates for Systemic Therapy: Complete Statistical AnalysisIndependent statistical analysis of Study of Subcutaneous Risankizumab Injection Compared to Oral Apremilast Tablets to Assess Change in Disease Activity And Adverse Events in Adult Participants With Moderate Plaque Psoriasis Who Are…
- Study Of Sunitinib In Combination With Cisplatin And 5-Fluorouracil In Patients With Advanced Gastric Cancer: Complete Statistical AnalysisIndependent statistical analysis of Study Of Sunitinib In Combination With Cisplatin And 5-Fluorouracil In Patients With Advanced Gastric Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Study Of Sunitinib Plus FOLFOX In Patients With Solid Tumors: Complete Statistical AnalysisIndependent statistical analysis of Study Of Sunitinib Plus FOLFOX In Patients With Solid Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00599924).
- Study Of Sunitinib With Capecitabine In Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Study Of Sunitinib With Capecitabine In Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00662025).
- Study Of Sunitinib With S-1 And Cisplatin For Gastric Cancer: Complete Statistical AnalysisIndependent statistical analysis of Study Of Sunitinib With S-1 And Cisplatin For Gastric Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00553696).
- Study of T3 for the Treatment of Fibromyalgia: Complete Statistical AnalysisIndependent statistical analysis of Study of T3 for the Treatment of Fibromyalgia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00903877).
- Study of TAC-101 as Second Line Treatment in Patients With Advanced Hepatocellular Carcinoma Who Received Sorafenib as First Line Therapy: Complete Statistical AnalysisIndependent statistical analysis of Study of TAC-101 as Second Line Treatment in Patients With Advanced Hepatocellular Carcinoma Who Received Sorafenib as First Line Therapy: primary endpoint results, effect estimate with confidence interval,…